BCHE and Alzheimer disease: As a result of the limited treatment options, cholinesterase inhibitors (ChEIs) (Donepezil, Galantamine, Rivastigmine) and Memantine, a partial antagonist of N-methyl-D-aspartate receptor (NMDAR), remain the primary treatment line for AD and non-AD dementias [8].